Pharmacy chains activity analysis

Pharmacy chains activity analysis

Russian pharmaceuticals retail chain segment evaluation, both on the level of the state and in particular regions. Pharmacy chains development forecast

Forecasting

Product sales and separate market development forecast, based on unique mathematical models

Business and marketing plan development

Development of detailed business-plans, required to evaluate the reasonability of project start

Search of partners for contract production in Russia

Potential partners search and evaluation, based on their technical opportunities, appropriate experience, and reputation

Monitoring of import substitution

assessment of the main trends of import substitution policies and localization processes in the pharmaceutical market in Russia, the key beneficiaries and companies at risk

Database Update: Pharmaceutical Drug Import to Russia (February 2017)

Friday, March 17, 2017

In January and February 2017, Russia imported 63.7 bln RUB worth of ready-made drugs (free circulation prices) and 14.5 bln RUB worth of in-bulk drugs, which are 4% and 51% higher than those of the same period of 2016, respectively. In monetary terms, the total import of pharmaceutical drugs has increased by 11% over the first two months of 2017.

The February performance does not seem that positive, though, as Russia imported 33.6 bln RUB worth of ready-made drugs, which is 7% lower than that of the same period of 2016. However, this can be explained by the increased activity of the importers in January. In physical terms, the import of ready-made drugs in January and February amounted to around 275.4 mln units, which is 3% higher than that of the same period of 2016. Despite the large increase in in-bulk imports, the total import of pharmaceuticals amounted to 5.83 bln minimum dosage units (MDU), with the long-term growth rate being negative (-3%).

Between January and February 2017, 95.4% of all imports of ready-made and in-bulk drugs was payed for in rubles, which is 1.4% higher than last year. The number of payments in dollars and euros has fallen, with only 4.1% of all payments. While in 2016 Russia imported from 50 countries, between January and February 2017 the number dropped to 48. However, the leaders are still the same, with Germany (17% of the import in monetary terms) and the Netherlands (11.1%).

Read more about pharmaceutical drug import to Russia (January performance) here: http://rncph.com/news/17_02_2017

Dynamics of import of pharmaceuticals, including homeopathic and seawater drugs, to Russia, free circulation prices including customs clearance, RUB (January 2016 – February 2017)

Share: